The DOI matches its Crossref record; 46 of the 48 references it cites were found in a registry or an index.
Ink4a/Arf and Oncogene-Induced Senescence Prevent Tumor Progression during Alternative Colorectal Tumorigenesis
Open accessAbstract
Colonic cancers with a serrated morphology have been proposed to comprise a molecularly distinct tumor entity following an alternative pathway of genetic alterations independently of APC mutations. We demonstrate that intestinal epithelial cell specific expression of oncogenic K-ras(G12D) in mice induces serrated hyperplasia, which is characterized by p16(ink4a) overexpression and induction of senescence. Deletion of Ink4a/Arf in K-ras(G12D) expressing mice prevents senescence and leads to invasive, metastasizing carcinomas with morphological and molecular alterations comparable to human KRAS mutated serrated tumors. Thus, we suggest that oncogenic K-ras represents a key player during an alternative, serrated pathway to colorectal cancer and hence propose RAS-RAF-MEK signaling apart from APC as an additional gatekeeper in colorectal tumor development.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Colon SSAs are mainly driven by activating BRAF mutations that trigger OIS 31,34,35 .”
From A complex secretory program orchestrated by the inflammasome controls paracrine senescence (2013) · cites this paper as [35]
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., & Thun, M. J. (2009) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20006 · Cited by 9,709
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., de Vries-Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,704
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168 · cited 1×
“APC mutations lead to chromosomal instability (CIN) and followed by additional mutations in tumor suppressors and oncogenes along the adenoma-carcinoma sequence ultimately to invasive cancer (Lengauer et al., 1998).”
BackgroundBoland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Kamangar, F., Dores, G. M., & Anderson, W. F. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2308 · Cited by 3,451
Flagged first, then by citations
2 of the 48 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278
The essence of senescence: Figure 1.
Kuilman, T., Michaloglou, C., Mooi, W. J., & Peeper, D. S. (2010) · Genes & Development · doi:10.1101/gad.1971610 · Cited by 2,038
Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties
Schwitalla, S., Fingerle, A. A., Cammareri, P., Nebelsiek, T., Göktuna, S. İ., Ziegler, P. K., Canli, Ö., Heijmans, J., Huels, D. J., Moreaux, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.12.012 · Cited by 1,098
Self-citationDe Sousa E Melo, F., Wang, X., Jansen, M., Fessler, E., Trinh, A., de Rooij, L. P. M. H., de Jong, J. H., de Boer, O. J., van Leersum, R., Bijlsma, M. F., et al. (2013) · Nature Medicine · doi:10.1038/nm.3174 · Cited by 771
Romagosa, C., Simonetti, S., López-Vicente, L., Mazo, A., Lleonart, M. E., Castellvi, J., & Ramon y Cajal, S. (2011) · Oncogene · doi:10.1038/onc.2010.614 · Cited by 509
The serrated pathway to colorectal carcinoma: current concepts and challenges
Bettington, M. L., Walker, N. I., Clouston, A. D., Brown, I., Leggett, B., & Whitehall, V. (2012) · Histopathology · doi:10.1111/his.12055 · Cited by 537
High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity
Schulz, M. D., Atay, Ç., Heringer, J., Romrig, F., Schwitalla, S., Aydın, B., Ziegler, P. K., Varga, J., Reindl, W., Pommerenke, C., et al. (2014) · Nature · doi:10.1038/nature13398 · Cited by 458
Self-citationJackstadt, R., van Hooff, S. R., Leach, J. D. G., Cortés-Lavaud, X., Lohuis, J. O., Ridgway, R. A., Wouters, V. M., Roper, J., Kendall, T. J., Roxburgh, C. S. D., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.08.003 · Cited by 438
Senescence-associated inflammatory responses: aging and cancer perspectives
Lasry, A., & Ben-Neriah, Y. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.02.009 · Cited by 408
BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
Yokota, T., Ura, T., Shibata, N., Takahari, D., Shitara, K., Nomura, M., Kondo, C., Mizota, A., Utsunomiya, S., Muro, K., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.19 · Cited by 399
A model for RAS mutation patterns in cancers: finding the sweet spot
Li, S., Balmain, A., & Counter, C. M. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0076-6 · Cited by 384
McLaughlin-Drubin, M. E., Crum, C. P., & Münger, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009933108 · Cited by 337
Schwitalla, S., Ziegler, P. K., Horst, D., Becker, V., Kerle, I., Begus-Nahrmann, Y., Lechel, A., Rudolph, K. L., Langer, R., Slotta-Huspenina, J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.11.014 · Cited by 296
Self-citationSenescent tumor cells lead the collective invasion in thyroid cancer
Kim, Y. H., Choi, Y. W., Lee, J., Soh, E. Y., Kim, J.-H., & Park, T. J. (2017) · Nature Communications · doi:10.1038/ncomms15208 · Cited by 253
Senescence: a new weapon for cancer therapy
Acosta, J. C., & Gil, J. (2012) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.11.006 · Cited by 235
Rad, R., Cadiñanos, J., Rad, L., Varela, I., Strong, A., Kriegl, L., Constantino‐Casas, F., Eser, S., Hieber, M., Seidler, B., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.014 · Cited by 227
Self-citationERKs in cancer: friends or foes?
Deschênes-Simard, X., Kottakis, F., Meloche, S., & Ferbeyre, G. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2381 · Cited by 186
Serrated neoplasia—role in colorectal carcinogenesis and clinical implications
IJspeert, J. E. G., Vermeulen, L., Meijer, G. A., & Dekker, E. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.73 · Cited by 192
Resveratrol Induces Premature Senescence in Lung Cancer Cells via ROS-Mediated DNA Damage
Luo, H., Yang, A., Schulte, B. A., Wargovich, M. J., & Wang, G. Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060065 · Cited by 181
Mouse models of colorectal cancer: Past, present and future perspectives
Bürtin, F., Mullins, C. S., & Linnebacher, M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i13.1394 · Cited by 183
Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer
Lemieux, É., Cagnol, S., Beaudry, K., Carrier, J. C., & Rivard, N. (2014) · Oncogene · doi:10.1038/onc.2014.416 · Cited by 164
Inamura, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041259 · Cited by 168
Morkel, M., Riemer, P., Bläker, H., & Sers, C. (2015) · Oncotarget · doi:10.18632/oncotarget.4750 · Cited by 146
Gala, M. K., Mizukami, Y., Le, L. P., Moriichi, K., Austin, T. R., Yamamoto, M., Lauwers, G. Y., Bardeesy, N. M., & Chung, D. C. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.10.045 · Cited by 145
Mouse models of intestinal cancer
Jackstadt, R., & Sansom, O. J. (2015) · The Journal of Pathology · doi:10.1002/path.4645 · Cited by 147
Oncogenic KRas Suppresses Inflammation-Associated Senescence of Pancreatic Ductal Cells
Lee, K. E., & Bar‐Sagi, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.020 · Cited by 138
Feng, Y., Bommer, G. T., Zhao, J., Green, M. E., Sands, E., Zhai, Y., Brown, K., Burberry, A., Cho, K. R., & Fearon, E. R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.05.007 · Cited by 132
Lannagan, T. R. M., Lee, Y. K., Wang, T., Roper, J., Bettington, M. L., Fennell, L., Vrbanac, L., Jonavicius, L., Somashekar, R., Gieniec, K. A., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315920 · Cited by 134
Do all lung adenocarcinomas follow a stepwise progression?
Yatabe, Y., Borczuk, A., & Powell, C. A. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.05.021 · Cited by 127
Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?
Yokota, T. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012799014968 · Cited by 127
Stressing the cell cycle in senescence and aging
Chandler, H., & Peters, G. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.07.005 · Cited by 119
TLR4 Activates the β-catenin Pathway to Cause Intestinal Neoplasia
Santaolalla, R., Sussman, D. A., Ruiz, J. R., Davies, J. M., Pastorini, C., España, C., Sotolongo, J. P., Burlingame, O., Bejarano, P. A., Philip, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063298 · Cited by 121
Prognostic significance of KRAS gene mutations in colorectal cancer--preliminary study.
Dinu, D., Dobre, M., Panaitescu, E., Bîrlă, R., Iosif, C., Hoara, P. A., Caragui, A., Boeriu, M., Constantinoiu, S. M., & Ardeleanu, C. M. (2014) · Europe PMC (PubMed Central) · Cited by 114
Targeted therapies: how personal should we go?
Martini, M., Vecchione, L., Siena, S., Tejpar, S., & Bardelli, A. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.164 · Cited by 112
Quantitation and Identification of Thousands of Human Proteoforms below 30 kDa
Durbin, K. R., Fornelli, L., Fellers, R. T., Doubleday, P. F., Narita, M., & Kelleher, N. L. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5b00997 · Cited by 111
Ray, K. C., Bell, K. M., Yan, J., Gu, G., Chung, C. H., Washington, M. K., & Means, A. L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016786 · Cited by 113
Colorectal serrated pathway cancers and precursors
O’Brien, M. J., Zhao, Q., & Yang, S. (2014) · Histopathology · doi:10.1111/his.12564 · Cited by 109
Chemotherapy-induced senescence, an adaptive mechanism driving resistance and tumor heterogeneity
Guillon, J., Petit, C., Toutain, B., Guette, C., Lelièvre, E., & Coqueret, O. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1652047 · Cited by 102
Pathology of Rodent Models of Intestinal Cancer: Progress Report and Recommendations
Washington, M. K., Powell, A. E., Sullivan, R., Sundberg, J. P., Wright, N., Coffey, R. J., & Dove, W. F. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.067 · Cited by 102
Liu, Y., Hawkins, O. E., Su, Y., Vilgelm, A. E., Sobolik, T., Thu, Y. M., Kantrow, S. M., Splittgerber, R. C., Short, S. P., Amiri, K. I., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201378 · Cited by 104
BRAFV600E cooperates with CDX2 inactivation to promote serrated colorectal tumorigenesis
Sakamoto, N., Feng, Y., Stolfi, C., Kurosu, Y., Green, M. E., Lin, J., Green, M. E., Sentani, K., Yasui, W., McMahon, M., et al. (2017) · eLife · doi:10.7554/elife.20331 · Cited by 100
Kriegl, L., Neumann, J., Vieth, M., Greten, F. R., Reu, S., Jung, A., & Kirchner, T. (2011) · Modern Pathology · doi:10.1038/modpathol.2011.43 · Cited by 99
Self-citationCellular senescence in gastrointestinal diseases: from pathogenesis to therapeutics
Frey, N., Venturelli, S., Zender, L., & Bitzer, M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.146 · Cited by 97
Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation
Rhodes, S. D., He, Y., Smith, A. E., Jiang, L., Lu, Q., Mund, J. A., Li, X., Bessler, W., Qian, S., Dyer, W., et al. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz095 · Cited by 97
Transcriptional regulation of cellular senescence
Lanigan, F., Geraghty, J. G., & Bracken, A. P. (2011) · Oncogene · doi:10.1038/onc.2011.34 · Cited by 95
Cellular senescence in cancer: clinical detection and prognostic implications
Domen, A., Deben, C., Verswyvel, J., Flieswasser, T., Prenen, H., Peeters, M., Lardon, F., & Wouters, A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02555-3 · Cited by 94
Liu, T., Guo, Z., Song, X., Liu, L., Dong, W., Wang, S., Xu, M., Yang, C., Wang, B., & Cao, H. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14984 · Cited by 95
Exploring and modelling colon cancer inter-tumour heterogeneity: opportunities and challenges
Buikhuisen, J. Y., Torang, A., & Medema, J. P. (2020) · Oncogenesis · doi:10.1038/s41389-020-00250-6 · Cited by 96
Genetic and epigenetic dependencies in colorectal cancer development
Parmar, S., & Easwaran, H. (2022) · Gastroenterology report · doi:10.1093/gastro/goac035 · Cited by 89
The Dual Roles of the Atypical Protein Kinase Cs in Cancer
Reina‐Campos, M., Díaz-Meco, M. T., & Moscat, J. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.07.010 · Cited by 86
RasGRP1 opposes proliferative EGFR–SOS1–Ras signals and restricts intestinal epithelial cell growth
Depeille, P., Henricks, L. M., van de Ven, R. A. H., Lemmens, E., Wang, C.-Y., Matli, M., Werb, Z., Haigis, K. M., Donner, D., Warren, R., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3175 · Cited by 80
Kriegl, L., Vieth, M. W., Kirchner, T., & Menssen, A. (2012) · Oncotarget · doi:10.18632/oncotarget.628 · Cited by 77
Self-citationRushworth, L. K., Kidger, A. M., Delavaine, L., Stewart, G., van Schelven, S., Davidson, J., Bryant, C., Caddye, E., East, P., Caunt, C. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1420159112 · Cited by 75
Lee, S. Y., Ju, M. K., Jeon, H. M., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1027453 · Cited by 69
Yu, K., Park, S., Jung, J., Seo, M., Hong, I., Kim, H., Seo, Y., Kang, T., Lee, J. Y., Kurtz, A., et al. (2012) · Stem Cell Research · doi:10.1016/j.scr.2012.11.002 · Cited by 65
Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming
Buj, R., Chen, C., Dahl, E. S., Leon, K. E., Kuskovsky, R., Maglakelidze, N., Navaratnarajah, M., Zhang, G., Doan, M. T., Jiang, H., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.07.084 · Cited by 66
Surveillance Guidelines Should Be Updated to Recognize the Importance of Serrated Polyps
Terdiman, J. P., & McQuaid, K. R. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.09.024 · Cited by 63
RAS Transformation Requires CUX1-Dependent Repair of Oxidative DNA Damage
Ramdzan, Z. M., Vadnais, C., Pal, R., Vandal, G., Cadieux, C., Leduy, L., Davoudi, S., Hulea, L., Yao, L., Karnezis, A. N., et al. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001807 · Cited by 66
Li, Z., Wang, Y., Yuan, C., Zhu, Y., Qiu, J., Zhang, W., Qi, B., Wu, H., Ye, J., Jiang, H., et al. (2014) · Laboratory Investigation · doi:10.1038/labinvest.2014.123 · Cited by 62
Nakanishi, Y., Durán, Á., L’Hermitte, A., Shelton, P. M., Nakanishi, N., Reina‐Campos, M., Huang, J., Soldevila, F., Baaten, B. J. G., Tauriello, D. V. F., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.09.013 · Cited by 59
USP5-Beclin 1 axis overrides p53-dependent senescence and drives Kras-induced tumorigenicity
Li, J., Wang, Y., Luo, Y., Liu, Y., Yi, Y., Li, J., Pan, Y., Li, W., You, W., Hu, Q., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35557-y · Cited by 63
Zhao, H. C., Li, Q., Wang, J., Su, X., Ng, K. M., Qiu, T., Shan, L., Ling, Y., Wang, L., Cai, J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049683 · Cited by 56
Davies, E. J., Durban, V. M., Méniel, V. S., Williams, G. T., & Clarke, A. R. (2013) · The Journal of Pathology · doi:10.1002/path.4312 · Cited by 54
BRAF: A Driver of the Serrated Pathway in Colon Cancer
Rustgi, A. K. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.06.008 · Cited by 52
Serrated Colorectal Cancer: The Road Less Travelled?
Nakanishi, Y., Díaz-Meco, M. T., & Moscat, J. (2019) · Trends in cancer · doi:10.1016/j.trecan.2019.09.004 · Cited by 55
Kohonen‐Corish, M. R. J., Tseung, J., Chan, C., Currey, N., Dent, O. F., Clarke, S. J., Bokey, L., & Chapuis, P. H. (2013) · International Journal of Cancer · doi:10.1002/ijc.28619 · Cited by 51
Knösel, T., Altendorf-Hofmann, A., Lindner, L. H., Issels, R. D., Hermeking, H., Schuebbe, G., Gibis, S., Siemens, H., Kampmann, E., & Kirchner, T. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2013-202106 · Cited by 50
Self-citationMileo, A. M., Venere, D. D., Abbruzzese, C., & Miccadei, S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/363827 · Cited by 48
Sessile serrated polyps and colon cancer prevention
Rashtak, S., Rego, R., Sweetser, S. R., & Sinicrope, F. A. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0264 · Cited by 47
Molecular and Histologic Considerations in the Assessment of Serrated Polyps
Yang, H.-M., Mitchell, J. M., Sepulveda, J. L., & Sepulveda, A. R. (2015) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0424-ra · Cited by 47
APC Mutation Marks an Aggressive Subtype of BRAF Mutant Colorectal Cancers
Fennell, L., Kane, A. M., Liu, C., McKeone, D., Fernando, W., Su, C., Bond, C., Jamieson, S., Dumenil, T. D., Patch, A., et al. (2020) · Cancers · doi:10.3390/cancers12051171 · Cited by 48
Thiem, S., Eissmann, M. F., Elzer, J., Jonas, A., Putoczki, T. L., Poh, A. R., Nguyen, P. M., Preaudet, A., Flanagan, D. J., Vincan, E., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3089 · Cited by 45
Pawlikowski, J. S., Adams, P. D., & Nelson, D. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.109728 · Cited by 52
Riemer, P., Sreekumar, A., Reinke, S., Rad, R., Schäfer, R., Sers, C., Bläker, H., Herrmann, B. G., & Morkel, M. (2014) · Oncogene · doi:10.1038/onc.2014.247 · Cited by 45
Escape from oncogene-induced senescence is controlled by POU2F2 and memorized by chromatin scars
Martínez‐Zamudio, R. I., Stefa, A., de Freitas, J. A. N. L. F., Vasilopoulos, T., Simpson, M., Doré, G. R. G., Roux, P., Galan, M. A., Chokshi, R. J., Bischof, O., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100293 · Cited by 47
Spatial resolution of cellular senescence dynamics in human colorectal liver metastasis
Garbarino, O., Lambroia, L., Basso, G., Marrella, V., Franceschini, B., Soldani, C., Pasqualini, F., Giuliano, D., Costa, G., Peano, C., et al. (2023) · Aging Cell · doi:10.1111/acel.13853 · Cited by 43
“Therapeutically, the presence of eSMCCs is a desirable final stage, recalling the historical role of senescence as being tumorprotective (Bennecke et al., 2010; Sieben et al., 2018).”
BackgroundLevanon, D., Bernstein, Y., Negreanu, V., Bone, K. R., Pozner, A., Eilam, R., Lotem, J., Brenner, O. J., & Groner, Y. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100168 · Cited by 43
Serrated colorectal cancer: preclinical models and molecular pathways
Aiderus, A., Barker, N., & Tergaonkar, V. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.09.011 · Cited by 42
Yoo, S. H., Park, B. H., Choi, J., Yoo, J. Y., Lee, S., Kim, Y., & Kim, K.-R. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.113 · Cited by 41
Experimental Murine Models for Colorectal Cancer Research
Neto, Í., Rocha, J. P., Gaspar, M. M., & Reis, C. P. (2023) · Cancers · doi:10.3390/cancers15092570 · Cited by 48
Welz, L., Kakavand, N., Hang, X., Laue, G., Ito, G., Silva, M. G., Plattner, C., Mishra, N., Tengen, F., Ogris, C., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.09.057 · Cited by 40
Kim, Y. H., & Park, T. J. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.1.295 · Cited by 42
Wu, X., Zou, T., Neng, C., Ni, J., Xu, W., Zhou, T., & Wang, X. (2014) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-12-2 · Cited by 38
Bongers, G., Muniz, L. R., Pacer, M. E., Iuga, A. C., Thirunarayanan, N., Slinger, E., Smit, M. J., Reddy, E. P., Mayer, L., Furtado, G. C., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.034 · Cited by 37
Cole, A. M., Ridgway, R. A., Derkits, S., Parry, L., Barker, N., Clevers, H. C., Clarke, A. R., & Sansom, O. J. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000101 · Cited by 35
The loss of MiR-139-5p promotes colitis-associated tumorigenesis by mediating PI3K/AKT/Wnt signaling
Mao, R., Zou, F., Yang, L., Lin, S., Li, Y., Ma, M., Yin, P., Liang, X., & Liu, J. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.10.008 · Cited by 36
Muta, Y., Linares, J. F., Martínez-Ordóñez, A., Durán, Á., Cid-Diaz, T., Kinoshita, H., Zhang, X., Han, Q., Nakanishi, Y., Nakanishi, N., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43690-5 · Cited by 35
The FBXO4 Tumor Suppressor Functions as a Barrier to Braf V600E -Dependent Metastatic Melanoma
Lee, E. K., Lian, Z., D'Andrea, K. P., Letrero, R., Sheng, W., Liu, S., Diehl, J. A., Pytel, D., Barbash, O., Schuchter, L. M., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00706-13 · Cited by 37
Pivotal Role of the Chromatin Protein Nupr1 in Kras-Induced Senescence and Transformation
Grasso, D., Bintz, J., Lomberk, G. A., Molejon, M. I., Loncle, C., Garcia, M. N., López‐Millán, B., Urrutia, R. A., & Iovanna, J. (2015) · Scientific Reports · doi:10.1038/srep17549 · Cited by 37
Genetics of the Serrated Pathway to Colorectal Cancer
Kedrin, D., & Gala, M. K. (2015) · Clinical and Translational Gastroenterology · doi:10.1038/ctg.2015.12 · Cited by 33
Ubiquitination in melanoma pathogenesis and treatment
Ma, J., Guo, W., & Li, C. (2017) · Cancer Medicine · doi:10.1002/cam4.1069 · Cited by 35
Dissecting cellular senescence and SASP in Drosophila
Ito, T., & Igaki, T. (2016) · Inflammation and Regeneration · doi:10.1186/s41232-016-0031-4 · Cited by 34
Ostermann, A. L., Wunderlich, C. M., Schneiders, L., Vogt, M. C., Woeste, M., Belgardt, B., Niessen, C. M., Martiny, B., Schauss, A. C., Frommolt, P., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0037-8 · Cited by 28
Non-canonical functions of SNAIL drive context-specific cancer progression
Paul, M., Schneeweis, C., Falcomatà, C., Shan, C., Rossmeisl, D., Koutsouli, S., Klement, C., Żukowska, M., Widholz, S. A., Jesinghaus, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36505-0 · Cited by 27
The DNA repair function ofCUX1contributes to radioresistance
Ramdzan, Z. M., Ginjala, V., Pinder, J. B., Chung, D., Donovan, C. M., Kaur, S. J., Leduy, L., Dellaire, G., Ganesan, S., & Nepveu, A. (2017) · Oncotarget · doi:10.18632/oncotarget.14875 · Cited by 30
Mo, A., Jackson, S. M., Varma, K., Carpino, A., Giardina, C. A., Devers, T. J., & Rosenberg, D. W. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0156 · Cited by 27
Matozaki, T., Kotani, T., Murata, Y., & Saito, Y. (2020) · Cancer Science · doi:10.1111/cas.14702 · Cited by 24
Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs
Kee, J. X., Yau, J. N. N., Muthuramalingam, R. P. K., Wang, X., Chng, W. H., Lopez‐Sanchez, A., Tay, K. K. W., Deng, L., Gibson, D., Bertrand, H. C., et al. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.5c00041 · Cited by 29
Oncogene‐induced senescence and melanoma: where do we stand?
Peeper, D. S. (2011) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2011.00933.x · Cited by 28
IKKα Promotes Intestinal Tumorigenesis by Limiting Recruitment of M1-like Polarized Myeloid Cells
Göktuna, S. İ., Canli, Ö., Bollrath, J., Fingerle, A. A., Horst, D. A., Diamanti, M. A., Pallangyo, C. K., Bennecke, M., Nebelsiek, T., Mankan, A. K., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.006 · Cited by 25
Self-citation
Metadata
- Authors
- Bennecke, M., Kriegl, L., Bajbouj, M., Retzlaff, K., Robine, S., Jung, A., Arkan, M. C., Kirchner, T., & Greten, F. R.
- Affiliations
- TUM Klinikum (DE)
- Pathologisches Institut (DE)
- Centre National de la Recherche Scientifique (FR)
- Corresponding author
- Greten, Florian R.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 18
- Issue
- 2
- Pages
- 135-146
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2166189096
- Cited by
- 186
- References
- 48
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 12 · 2023: 12 · 2022: 10 · 2021: 5 · 2020: 7 · 2019: 14 · 2018: 9 · 2017: 12 · 2016: 9 · 2015: 14 · 2014: 16 · 2013: 16 · 2012: 17
- FWCI
- 12.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Keywords
- Ink4a/Arf, oncogene-induced senescence, KRAS G12D, colorectal carcinogenesis, p16INK4a, metastatic colorectal cancer, Ras/Raf/MEK signaling, gatekeeper genes, tumor progression
- MeSH terms
- Animals, Cell Division, Humans, Immunohistochemistry, Mice, Inbred C57BL, Mutation, Oncogenes, Genes, ras, Colorectal Neoplasms, Signal Transduction, Cellular Senescence, Genes, APC, Disease Progression, Cyclin-Dependent Kinase Inhibitor p16, Wnt Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review